It was co-led by Silicon Valley’s Danhua Capital (DHVC) and 6 Dimensions Capital, a healthcare investment group formed through the merger of Frontline Bioventures and Wuxi Healthcare Ventures.
SINGAPORE (Jan 31): A biotech company with offices in Singapore and San Francisco, Engine Biosciences, says it has secured US$10 million ($13.1 million) in seed funding from both American and Asian investors.
The heavily-oversubscribed seed round makes it the largest seed financing recorded in Southeast Asia, and one of the largest in Asia in the tech and biotech industries, according to Engine.
